Catalyst
Slingshot members are tracking this event:
FDA Approves Metformin Intellipharmaceutics' (IPCI) Generic Form of Bristol-Myers Squibb's (BMY) Type 2 Diabetes Med Glucophage XR
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 25, 2017
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Fda, Approval, Metformin, Type 2 Diabetes, Glucophage Xr
